This study assumes a positivist approach. This approach assumes that the relationship between observable and measurable things can be identified by careful observation, (Taylor et al 2001). In this study one of the methods used to assess compliance was tablet count which in theory indicates the extent of compliance and so gives meaning to the investigator. Furthermore, the study adopts the principle of causality in which the state of one variable – medicine review and education programme may cause the state of the other variable – improved medicine compliance, an exposure-outcome association. The study also adopts the standard research method for the positivist approach which is the Randomised Controlled Trial (RCT) that takes place in a controlled environment (GP) with subjects often the result of an intervention, (Taylor et al 2001). Any measurable improvement is presumed to be the result of the intervention.
The study adopted an Intervention design which is a prospective cohort study (Karwowski 2001). Participants received three visits from the clinical pharmacist. On visit 1, the investigator tested the patients’ understanding of their medication via a structured questionnaire followed by rationalisation of the intervention patients’ medication. The second visit involved one month’s medication supply being issued to all patients while intervention patients received education on medicines use by the investigator. The final visit took place three weeks after visit 2 where patients again received one month’s medication supply and education on medicines use. Data was acquired qualitatively using a structured questionnaire and quantitatively by tablet count. The data was analysed by comparing overall mean compliance of both groups using the Mann-Whitney U-test while participants who were aware of the purpose of their medicines from visits 1 and 3 were compared by the Chi-squared test.
The study received approval from the Local Research Ethics Committee and gained informed consent from participants although the author does not describe how consent was obtained.
The evidence provided by the study is direct, i.e. the use of the intervention and the resultant outcome occurred in the same study, in contrast to indirect evidence where at least two bodies of evidence are required to relate the integration of the intervention to the observed outcome, (Eddy 1997). The authors reported an increase in compliance on the basis of one study. Ideally, the health care intervention would be evaluated over multiple studies. This would provide a larger sample size and increase the likelihood of establishing whether the increase in compliance was attributable to chance.
Subjects were randomly assigned to either the control or intervention group. This helped ensure that both groups were equivalently matched prior to treatment enhancing the internal validity of the study. The authors avoided asking for volunteers as this would be unrepresentative of the older population as they are likely to have good compliance. The method used to calculate the required sample size of 160 participants was statistically valid so the sample size is sufficient. Exclusion criteria mean results have limited applicability, for example, many older people in population may be reliant on another person to administer their medicines. In addition, elderly carers may also suffer from memory problems.
The authors randomly allocated subjects which ensured the two groups were well matched with regards to age, sex, social circumstances and number of medicines taken so minimising selection bias. However, the refusal of 20 participants to take part may have caused some selection bias, (Aschengrau et al 2003). There were no differences in patient care other than the intervention of regime rationalization and education programme being studied avoiding performance bias. However, the nature of the intervention requires the active participation of the subjects and so the patients may not have been subjected to a blinded trial. This may have affected their subsequent behaviour if they were aware of the purpose of the intervention. Although nine patients dropped out, reducing the sample size slightly, there is no attrition bias because sample attrition was not systematic, i.e. patients who dropped out did not share unique characteristics. The authors confirm this and mention that the remaining subjects remained closely matched. The authors also used a structured questionnaire to minimise observer bias while an independent observer reviewed all subject responses to achieve objectivity as it was not possible to conceal the allocation of the intervention from the investigator.
The study does not state if allowances were made for drop-outs and non-compliance when the sample size of 160 was calculated. The study has the minimum power required (0.8). One of the methods used to measure compliance – tablet count, suffers from poor credibility as it may not reflect compliance behaviour due to medicine dumping and gives little impression of the timing of doses or drug-free intervals. Also, patient knowledge and compliance were assessed three weeks after visit 2 which does not provide a long enough follow up as one month is the standard measure for chronic medication, (Armour et al 2001).
The conclusion makes clear the distinction between the quantitative findings of the study and the translation of the results into meaningful explanation. The authors conclude with respect to the research question that patient knowledge and compliance in the short term significantly increases upon exposure to a medicine review and education programme. This was justified by the study’s results for knowledge of medicines which found a tenfold increase for the intervention patients compared to the increase for the control patients. The mean compliance score was also higher (11.8%) than that of the control group.
The study was conducted in natural settings, i.e. patient homes and so is applicable to wider settings, (Blanche et al 2008). However, the study involved one investigator who educated patients on their use of medicines and so the findings may be researcher dependent, (Smith 2002). Moreover, the study consists of highly specific inclusion and exclusion criteria which limit its applicability to older patients in everyday clinical practice. The study does not suffer from measures of compliance as the nature of the target population dictated that tablet count and patient reports were the only suitable methods available. However, the subjects were selected from one GP practice in a suburban Leeds area which may not be representative of the compliance of older patients elsewhere.
Previous studies have suggested that a compliance figure of 85% is needed for older patients to benefit from treatment, (Raynor et al 1993). This study has found that the implementation of a medicine review and education programme surpassed this compliance figure in the short term. This study is more substantial than a previous one which assessed compliance of elderly patients in the hospital setting, (Lowe et al 1995). Although both studies adopted an identical study design (RCT), this study recruited a sample that is almost twice the size and provided a longer follow up duration allowing more time for the effect of the intervention to be revealed. Furthermore, the experimental population are more representative of the patients who will ultimately receive the intervention as older people are generally treated in general practice more often.
In conclusion, the study highlights a significant improvement in patient compliance and awareness of medicines for older patients in primary care following a medicines review and education programme intervention. The sample size was sufficient to meet the study’s aims while the study design was most appropriate for the purpose of the study. However, several limitations of the study exist including issues of external validity, duration of follow up, number of sites and exclusion criteria.
Word Count: 1650
References
Taylor K, Harding G, (2001), Pharmacy Practice. Publisher; CRC Press. Edition: illustrated
Karwowski W, (2001), International encyclopedia of ergonomics and human factors. Publisher; Taylor and Francis. Edition: illustrated
Eddy, D.M. Investigational Treatments: How Strict Should We Be? , Journal of the American Medical Association 278 (1997), pp. 179-185
Aschengrau A, Seage GR, (2003), Essentials of Epidemiology in Public Health. Publisher; Jones & Bartlett Publishers. Edition: illustrated
Armour D, Cairns C, (2001), Medicines in the Elderly. Publisher; Pharmaceutical Press. Edition: illustrated
Blanche MT, Durrheim K, Painter D, (2008), Research in Practice. Publisher; Juta and Company Limited. Second edition
Smith F,(2002), Research methods in pharmacy practice. Publisher; Pharmaceutical Press.
Raynor DK, Booth TG, Blenkinsopp A. Effects of computer generated reminder charts on patients’ compliance with drug regimes, Br Med J 306 (1993), pp. 1158-1161
Lowe CJ, Raynor DK, Courtney EA, Purvis J, Teale C. Effects of self-medication programme on knowledge of drugs and compliance with treatment in elderly patients, Br Med J 310 (1995), pp. 1229-1231
Greenhalgh T. How to read a paper: getting your bearings (deciding what a paper is all about, BMJ 315 (1997), pp. 243-246
Greenhalgh T, Taylor R. How to read a paper: Papers that go beyond numbers (qualitative research), BMJ 315 (1997), pp. 740-743